Concepedia

Intellicell Biosciences (United States)

IB

Statistics

Publications

20

Citations

1.1K

Authors

2

Location

New York, United States

Intellicell Biosciences (United States) is a company institution in New York, United States known for medicine, pharmacology, and oncology.

ROR

Top concepts

Publications

20

Activation of Gcn2 by small molecules designed to be inhibitors

Kenneth Carlson, Millie M. Georgiadis, Feven Tameire et al. · Journal of Biological Chemistry · 2023 · 66 citations · Full text

, , +9

Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab

Clinical Cancer Research · 2022 · 63 citations · Full text

, , +17

A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells

Verónica Calvo, Wei Zheng, Anna Adam‐Artigues et al. · Clinical Cancer Research · 2023 · 43 citations · Full text

, , +17

PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors

Michael E. Stokes, Verónica Calvo, Sho Fujisawa et al. · Clinical Cancer Research · 2023 · 28 citations · Full text

, , +15

Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice

Charanya Muralidharan, Fei Huang, Jacob R. Enriquez et al. · Journal of Clinical Investigation · 2024 · 18 citations · Full text

, , +17

1–5 of 20

Authors

2

  1. MF
    Maria Fumagalli

    Intellicell Biosciences (United States), United States

    29 publications · 46 citations

    2

    h-index

  2. JE
    Jiayi E. Wang

    Intellicell Biosciences (United States), United States

    4 publications · 29 citations

    2

    h-index

1–2 of 2